Press Releases Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Market Closed - NSE India S.E. Other stock markets 05:13:55 12/06/2024 pm IST			5-day change	1st Jan Change
1,097 ^INR	+1.12%		+9.30%	+59.16%

30/05	India's pharma export sales to grow faster this year, trade body says	RE
27/05	Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals	06/05	AQ
Zydus launches Mirabegron Extended-Release Tablets in the US	22/04	BU
PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines	29/23/29	AQ
Zydus Lifesciences : Loss of Share Certificates	28/22/28	PU
Tetanus Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space \| DelveInsight	18/22/18	AQ
Hepatitis A Pipeline Landscape Analysis of 3+ Companies by DelveInsight	12/22/12	AQ
Zydus Lifesciences : General updates	07/22/07	PU
BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY for the Treatment of MoCD Type A	21/22/21	AQ
Zydus Lifesciences : receives final approval from the USFDA for Lenalidomide Capsules 5 mg, 10 mg, 15 mg and 25 mg	13/22/13	PU
Zydus Lifesciences : receives final approval and 180 days shared exclusivity from the USFDA for Cariprazine Capsules	12/22/12	PU
Zydus Lifesciences : announces positive Phase 2 Proof-of-Concept of NLRP3 inhibitor, ZYIL1 in patients with Cryopyrin Associated Periodic Syndrome (CAPS)	07/22/07	PU
Zydus Lifesciences : announces Phase IV DREAM-CKD trial to generate Real World Evidence of Desidustat in patients with Chronic Kidney Disease induced anemia	30/22/30	PU
Zydus Lifesciences : Transcript of the 27th Annual General Meeting	27/22/27	PU
Zydus Lifesciences : Loss of share certificate	24/22/24	PU
Zydus Lifesciences : Q1 FY23 Earnings Call Transcript13 August 2022 Format	13/22/13	PU
Zydus Lifesciences : receives final approval from the USFDA for Prochlorperazine Maleate Tablets	12/22/12	PU
BridgeBio Pharma, Sentynl Therapeutics and Medison Pharma Announce Approval in Israel for NULIBRY (fosdenopterin) for the Treatment of MoCD Type A	11/22/11	AQ
Zydus Lifesciences : Earnings Call Audio Q1 FY23 – August 202210 August 2022 Format	10/22/10	PU
Zydus Lifesciences : Financial Performance for Q1 FY23	10/22/10	PU
Zydus Lifesciences : August 2022	10/22/10	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Press Releases

Filters